Adtran price target lowered to $11 from $15 at Rosenblatt

Rosenblatt lowered the firm’s price target on Adtran (ADTN) to $11 from $15 and keeps a Buy rating on the shares. The firm believes the March quarter results will be “generally solid” for the optical sector. However, none of the companies are immune to the negative impact to gross margins from higher tariffs, or from a meaningful macro slowdown, related to higher prices and general business environment uncertainty, likely to hit in the second half of 2025, the analyst tells investors in a research note. As such, Rosenblatt cut price targets in its coverage by an average of 19%.